Thermal Energy International (TMG) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
25 Nov, 2025Executive summary
Year-to-date revenue reached a record $23.0 million, up 25% year-over-year, despite a 4.1% decline in Q3 revenue to $5.8 million, mainly due to lower heat recovery project revenues.
EBITDA for Q3 was negative ($130,000 to $167,000), with a net loss of $400,000; trailing 12-month EBITDA remained positive at $0.76 million to $1.1 million, and trailing 12-month net income was $230,000.
Significant investments of $2.5 million over the past two years in growth, R&D, and team expansion are expected to drive profitability in fiscal 2026 and beyond.
Business development pipeline and order backlog remain strong, positioning for future growth.
Financial highlights
Trailing 12-month revenue was $30.5 million, up 15% to 76% over two years.
Q3 gross profit was $2.3 million, with a gross margin of 39%, down from 50% in Q3 2024.
Cash and cash equivalents at quarter end were $5.1 million; working capital was $2.4 million.
Long-term debt reduced to $1.4 million, down by $2.1 million over two years; net working capital increased by $600,000, funded by internal cash flow.
Operating expenses increased due to higher headcount, travel, and inflation, but Q3 expenses were $379,000 lower year-over-year due to foreign exchange gains.
Outlook and guidance
Management expects recent investments to drive higher revenue and profitability in fiscal 2026 and beyond, with a focus on maximizing returns from prior investments.
No additional growth-oriented expenses planned for the coming quarter.
Business development pipeline remains robust, with strong demand for energy efficiency and carbon reduction solutions.
Latest events from Thermal Energy International
- Record revenue, surging profits, and a robust order backlog signal strong growth momentum.TMG
Q2 20262 Feb 2026 - Record revenue, EBITDA, and order backlog signal strong growth and future momentum.TMG
Q4 202420 Jan 2026 - Record revenue, rising backlog, and growth investments support a strong outlook.TMG
Q1 202517 Jan 2026 - Record revenue and strong backlog highlight growth, despite margin and profit pressure.TMG
Q2 20259 Jan 2026 - Record Q1 order intake and backlog, pharma growth, and debt reduction drive strong outlook.TMG
Q1 202629 Oct 2025 - Record order backlog, new sales channels, and digital tools drive growth and margin expansion.TMG
Planet MicroCap Showcase: TORONTO 202523 Oct 2025 - Record revenue, margin gains, and a $24.3M backlog drive strong growth for H2 2026.TMG
Q4 202523 Sep 2025